Saint Jude Pharmaceuticals, LLC is categorized under Mail Order Pharmaceuticals in Orlando, FL and active since 2010.
Saint Jude Pharmaceuticals, LLC was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Mail Order Pharmaceuticals business, which does work in the B2C market, and is classified as a Mail Order Pharmaceuticals, under code number by the NAICS.
If you are seeking more information, feel free to contact Sarveshwar Sharma at the company’s single location by writing to 1743 Park Center Drive # 300, Orlando, Florida FL 32835 or by phoning (407) 539-0086. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Saint Jude Pharmaceuticals, LLC |
| Contact Person: | Sarveshwar Sharma |
| Address: | 1743 Park Center Drive # 300, Orlando, Florida 32835 |
| Phone Number: | (407) 539-0086 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Mail Order Pharmaceuticals |
| Share This Business: |
Saint Jude Pharmaceuticals, LLC was started in 2010 to provide professional Mail Order Pharmaceuticals under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Sarveshwar Sharma for inquiries that concern Saint Jude Pharmaceuticals, LLC by calling the company number (407) 539-0086, as your correspondence is most welcome. Additionally, the physical location of the single location of Saint Jude Pharmaceuticals, LLC can be found at the coordinates 28.52094,-81.47405 as well as the street address 1743 Park Center Drive # 300 in Orlando, Florida 32835.
For its online presence, you may visit Saint Jude Pharmaceuticals, LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.